FDA Inspection 1069980 — Lilly del Caribe, Inc.
The FDA completed an inspection of Lilly del Caribe, Inc. on September 27, 2018 in Carolina, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Carolina, PR (United States)